Vaccine could be in use by 2024 if next year’s human trials are successfulThe Oxford team that has produced a successful coronavirus vaccine is about to enter the final stage of human trials in its quest for an inoculation against malaria. In an interview with the Times, Hill said malaria was a public health emergency. And it’s going to be very low priced.”The vaccine could be in use by 2024 if the final human trials are successful, he said. The institute’s coronavirus vaccine is also intended to be cheap and available at scale in developing countries. It comes as the Oxford/AstraZeneca coronavirus vaccine awaits regulatory approval for use in the UK.

Source: The Guardian December 05, 2020 11:23 UTC